Why is RSV different from other viruses?

Journal of Medical Virology

Volumn 85, Issue 5, 2013, Pages 933-934

  Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

AIRWAY OBSTRUCTION; ANTIVIRAL THERAPY; CYTOPATHOGENIC EFFECT; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; KENYA; NOTE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; TREATMENT DURATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS REPLICATION;

FEMALE; HUMANS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; VIRUS DISEASES;

RICE STRIPE VIRUS;

EID: 84875685728     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23547     Document Type: Note

References (8)

1. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, Meyers R, Gollob J, Vaishnaw A. 2010. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci USA 107:8800-8805.
2. Empey KM, Peebles RS, Jr., Kolls JK. 2010. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin Infect Dis 50:1258-1267.
3. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF. 2012. Pathogenesis of influenza virus infections: The good, the bad and the ugly. Curr Opin Virol 2:276-286.
4. Lemanske RF, Jr., Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, Kirk CJ, Reisdorf E, Roberg KA, Anderson EL, Carlson-Dakes KT, Adler KJ, Gilbertson-White S, Pappas TE, DaSilva DF, Tisler CJ, Gern JE. 2005. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116:571-577.
5. Olszewska W, Ispas G, Schnoeller C, Sawant D, Van de CT, Nauwelaers D, Van KB, Roymans D, De MM, Rouan MC, Van RP, Bonfanti JF, Van VF, Koul A, Vanstockem M, Andries K, Sowinski P, Wang B, Openshaw P, Verloes R. 2010. Antiviral and lung protective activity of a novel RSV fusion inhibitor in a mouse model. Eur Respir J 38:401-408.
6. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, Herrera G, Erdman D, Hall CB, Seither R, Griffin MR. 2006. The underrecognized burden of influenza in young children. N Engl J Med 355:31-40.
7. Tregoning JS, Schwarze J. 2010. Respiratory viral infections in infants: Causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 23:74-98.
8. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra S, McKinney PL, Reed JL, Welliver RC, Sr. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195:1126-1136.